Implication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma

Pathology Research and Practice

Volumn 213, Issue 4, 2017, Pages 364-372

  Chen, Wen jie ^a   Gan, Ting qing ^a   Qin, Hui ^a   Huang, Su ning ^a   Yang, Li hua ^a   Fang, Ye ying ^a   Li, Zu yun ^a   Pan, Lin jiang ^a   Chen, Gang ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Carcinoma; Computational biology; MicroRNAs; Non small cell lung

Indexed keywords

FOXG1 PROTEIN; MICRORNA 375; PEPTIDES AND PROTEINS; TRANSCRIPTION FACTOR PAX6; UNCLASSIFIED DRUG; WNT5A PROTEIN; MICRORNA; MIRN375 MICRORNA, HUMAN; TRANSCRIPTOME;

ADULT; ARTICLE; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA BINDING; DNA SEQUENCE; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LUNG CARCINOGENESIS; MALE; NERVE CELL DIFFERENTIATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RNA SEQUENCE; SQUAMOUS CELL LUNG CARCINOMA; AGED; GENE EXPRESSION PROFILING; GENETICS; LUNG TUMOR; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 85012934934     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2017.01.007     Document Type: Article

References (40)

1. [1] Chen, W., Zheng, R., Zhang, S., Zhao, P., Zeng, H., Zou, X., Report of cancer incidence and mortality in China, 2010. Ann. Transl. Med., 2, 2014, 61.
2. [2] Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics: 2016. CA. Cancer J. Clin. 66 (2016), 7–30.
3. [3] Travis, W.D., Brambilla, E., Nicholson, A.G., Yatabe, Y., Austin, J.H., Beasley, M.B., Chirieac, L.R., Dacic, S., Duhig, E., Flieder, D.B., Geisinger, K., Hirsch, F.R., Ishikawa, Y., Kerr, K.M., Noguchi, M., Pelosi, G., Powell, C.A., Tsao, M.S., Wistuba, I., The 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J. Thorac. Oncol. 10 (2015), 1243–1260.
4. [4] Bartel, D.P., MicroRNAs: genomics biogenesis, mechanism, and function. Cell 116 (2004), 281–297.
5. [5] Su, H., Yang, J.R., Xu, T., Huang, J., Xu, L., Yuan, Y., Zhuang, S.M., MicroRNA-101 down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 69 (2009), 1135–1142.
6. [6] Ma, L., Teruya-Feldstein, J., Weinberg, R.A., Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449 (2007), 682–688.
7. [7] Sun, D., Lee, Y.S., Malhotra, A., Kim, H.K., Matecic, M., Evans, C., Jensen, R.V., Moskaluk, C.A., Dutta, A., miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. Cancer Res. 71 (2011), 1313–1324.
8. [8] Esquela-Kerscher, A., Slack, F.J., Oncomirs – microRNAs with a role in cancer. Nature reviews. Cancer 6 (2006), 259–269.
9. [9] Poy, M.N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., Macdonald, P.E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., Stoffel, M., A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432 (2004), 226–230.
10. [10] He, X.X., Chang, Y., Meng, F.Y., Wang, M.Y., Xie, Q.H., Tang, F., Li, P.Y., Song, Y.H., Lin, J.S., MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 31 (2012), 3357–3369.
11. [11] Chen, G., Kronenberger, P., Teugels, E., Umelo, I.A., De Greve, J., Effect of siRNAs targeting the EGFR T790M mutation in a non-small cell lung cancer cell line resistant to EGFR tyrosine kinase inhibitors and combination with various agents. Biochem. Biophys. Res. Commun. 431 (2013), 623–629.
12. [12] Chen, G., Kronenberger, P., Teugels, E., Umelo, I.A., De Greve, J., Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab. BMC Med., 10, 2012, 28.
13. [13] Chen, G., Kronenberger, P., Teugels, E., De Greve, J., Influence of RT-qPCR primer position on EGFR interference efficacy in lung cancer cells. Biol. Proced. Online, 13, 2011, 1.
14. [14] Chen, G., Umelo, I.A., Lv, S., Teugels, E., Fostier, K., Kronenberger, P., Dewaele, A., Sadones, J., Geers, C., De Greve, J., miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. PLoS One, 8, 2013, e60317.
15. [15] Chen, G., Noor, A., Kronenberger, P., Teugels, E., Umelo, I.A., De Greve, J., Synergistic effect of afatinib with su11274 in non-small cell lung cancer cells resistant to gefitinib or erlotinib. PloS Pne, 8, 2013, e59708.
16. [16] Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001), 402–408.
17. [17] Chen, G., Kronenberger, P., Umelo, I.A., Teugels, E., De Greve, J., Quantification of epidermal growth factor receptor T790 M mutant transcripts in lung cancer cells by real-time reverse transcriptase-quantitative polymerase chain reaction. Anal. Biochem. 398 (2010), 266–268.
18. [18] Smythe, T., Limma: Linear Models for Microarray. 2004.
19. [19] Yu, L., Todd, N.W., Xing, L., Xie, Y., Zhang, H., Liu, Z., Fang, H., Zhang, J., Katz, R.L., Jiang, F., Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int. J. Cancer 127 (2010), 2870–2878.
20. [20] Li, Y., Jiang, Q., Xia, N., Yang, H., Hu, C., Decreased expression of microRNA-375 in nonsmall cell lung cancer and its clinical significance. J. Int. Med. Res. 40 (2012), 1662–1669.
21. [21] Jin, Y., Liu, Y., Zhang, J., Huang, W., Jiang, H., Hou, Y., Xu, C., Zhai, C., Gao, X., Wang, S., Wu, Y., Zhu, H., Lu, S., The expression of miR-375 is associated with carcinogenesis in three subtypes of lung cancer. PLoS One, 10, 2015, e0144187.
22. [22] Mathe, E.A., Nguyen, G.H., Bowman, E.D., Zhao, Y., Budhu, A., Schetter, A.J., Braun, R., Reimers, M., Kumamoto, K., Hughes, D., Altorki, N.K., Casson, A.G., Liu, C.G., Wang, X.W., Yanaihara, N., Hagiwara, N., Dannenberg, A.J., Miyashita, M., Croce, C.M., Harris, C.C., MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin. Cancer Res. 15 (2009), 6192–6200.
23. [23] Kinoshita, T., Nohata, N., Yoshino, H., Hanazawa, T., Kikkawa, N., Fujimura, L., Chiyomaru, T., Kawakami, K., Enokida, H., Nakagawa, M., Okamoto, Y., Seki, N., Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma. Int. J. Oncol. 40 (2012), 185–193.
24. [24] He, Q., Chen, Z., Cabay, R.J., Zhang, L., Luan, X., Chen, D., Yu, T., Wang, A., Zhou, X., microRNA-21 and microRNA-375 from oral cytology as biomarkers for oral tongue cancer detection. Oral Oncol. 57 (2016), 15–20.
25. [25] Kong, K.L., Kwong, D.L., Chan, T.H., Law, S.Y., Chen, L., Li, Y., Qin, Y.R., Guan, X.Y., MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 61 (2012), 33–42.
26. [26] Liu, A.M., Poon, R.T., Luk, J.M., MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem. Biophys. Res. Commun. 394 (2010), 623–627.
27. [27] Tsukamoto, Y., Nakada, C., Noguchi, T., Tanigawa, M., Nguyen, L.T., Uchida, T., Hijiya, N., Matsuura, K., Fujioka, T., Seto, M., Moriyama, M., MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res. 70 (2010), 2339–2349.
28. [28] Wang, F., Li, Y., Zhou, J., Xu, J., Peng, C., Ye, F., Shen, Y., Lu, W., Wan, X., Xie, X., miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. Am. J. Pathol. 179 (2011), 2580–2588.
29. [29] Sellheyer, K., Basal cell carcinoma: cell of origin: cancer stem cell hypothesis and stem cell markers. Br. J. Dermatol. 164 (2011), 696–711.
30. [30] Zhou, Y.H., Tan, F., Hess, K.R., Yung, W.K., The expression of PAX6 PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival. Clin. Cancer Res. 9 (2003), 3369–3375.
31. [31] Cheng, Q., Cao, H., Chen, Z., Ma, Z., Wan, X., Peng, R., Jiang, B., PAX6, a novel target of miR-335, inhibits cell proliferation and invasion in glioma cells. Mol. Med. Rep. 10 (2014), 399–404.
32. [32] Mishra, D.K., Chen, Z., Wu, Y., Sarkissyan, M., Koeffler, H.P., Vadgama, J.V., Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells. Mol. Cancer Ther. 9 (2010), 33–45.
33. [33] Zhang, X., Yang, X., Wang, J., Liang, T., Gu, Y., Yang, D., Down-regulation of PAX6 by promoter methylation is associated with poor prognosis in non small cell lung cancer. Int. J. Clin. Exp. Path. 8 (2015), 11452–11457.
34. [34] Bhinge, A., Namboori, S.C., Bithell, A., Soldati, C., Buckley, N.J., Stanton, L.W., MiR-375 is essential for human spinal motor neuron development and may be involved in motor neuron degeneration. Stem Cells (Dayton, Ohio) 34 (2016), 124–134.
35. [35] Torii, K., Nishizawa, K., Kawasaki, A., Yamashita, Y., Katada, M., Ito, M., Nishimoto, I., Terashita, K., Aiso, S., Matsuoka, M., Anti-apoptotic action of Wnt5a in dermal fibroblasts is mediated by the PKA signaling pathways. Cell. Signal. 20 (2008), 1256–1266.
36. [36] MacLeod, R.J., Hayes, M., Pacheco, I., Wnt5a secretion stimulated by the extracellular calcium-sensing receptor inhibits defective Wnt signaling in colon cancer cells. Am. J. Physiol. Gastrointest. Liver Physiol. 293 (2007), G403–411.
37. [37] Yao, L., Sun, B., Zhao, X., Zhao, X., Gu, Q., Dong, X., Zheng, Y., Sun, J., Cheng, R., Qi, H., An, J., Overexpression of Wnt5a promotes angiogenesis in NSCLC. BioMed Res. Int., 2014, 2014, 832562.
38. [38] Shojima, K., Sato, A., Hanaki, H., Tsujimoto, I., Nakamura, M., Hattori, K., Sato, Y., Dohi, K., Hirata, M., Yamamoto, H., Kikuchi, A., Wnt5a promotes cancer cell invasion and proliferation by receptor-mediated endocytosis-dependent and -independent mechanisms, respectively. Sci. Rep., 5, 2015, 8042.
39. [39] Chan, D.W., Liu, V.W., To, R.M., Chiu, P.M., Lee, W.Y., Yao, K.M., Cheung, A.N., Ngan, H.Y., Overexpression of FOXG1 contributes to TGF-beta resistance through inhibition of p21WAF1/CIP1 expression in ovarian cancer. Br. J. Cancer 101 (2009), 1433–1443.
40. [40] Li, J.V., Chien, C.D., Garee, J.P., Xu, J., Wellstein, A., Riegel, A.T., Transcriptional repression of AIB1 by FoxG1 leads to apoptosis in breast cancer cells. Mol. Endocrinol. (Baltim. Md.) 27 (2013), 1113–1127.